VIRUPOS

This brand name is authorized in Australia, Germany, Hong Kong, Malta, New Zealand, Poland

Active ingredients

The drug VIRUPOS contains one active pharmaceutical ingredient (API):

1 Aciclovir
UNII X4HES1O11F - ACYCLOVIR

Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation.

Read about Aciclovir

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VIRUPOS Eye ointment Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01AD03 Aciclovir S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AD Antivirals
Discover more medicines within S01AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 1002R, 5501M
Country: DE Bundesinstitut fรผr Arzneimittel und Medizinprodukte Identifier(s): 07136323
Country: HK Department of Health Drug Office Identifier(s): 60697
Country: MT Medicines Authority Identifier(s): AA565/52001
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 17704
Country: PL Rejestru Produktรณw Leczniczych Identifier(s): 100177089

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.